Dendreon Turns To Convertible Offering - Forbes
Published by Google Inc. May 30th, 2007 in Google FDA News, Regulatory Affairs
 Seeking Alpha |
Dendreon Turns To Convertible Offering Forbes, NY - In the wake of the Food and Drug Administration's decision to delay the approval of its prostate cancer drug Provenge–until interim or final results of the … Ahead of the Bell: Provenge Protest |